ARDC Research Link Australia Research Link Australia   BETA Research
Link
Australia
  • ARDC Newsletter Subscribe
  • Contact Us
  • Home
  • About
  • Feedback
  • Explore Collaborations
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation

Need help searching? View our Search Guide.

Advanced Search

Current Selection
Research Topic : INFECTIOUS RNA
Australian State/Territory : VIC
Field of Research : Innate Immunity
Clear All
Filter by Field of Research
Innate Immunity (8)
Cellular Immunology (5)
Immunology (5)
Signal Transduction (2)
Bacteriology (1)
Biochemistry and Cell Biology (1)
Cell Development, Proliferation and Death (1)
Enzymes (1)
Infectious Agents (1)
Medical Bacteriology (1)
Medical Infection Agents (incl. Prions) (1)
Medical Microbiology (1)
Microbiology (1)
Receptors and Membrane Biology (1)
Reproduction (1)
Structural Biology (incl. Macromolecular Modelling) (1)
Virology (1)
Filter by Socio-Economic Objective
Infectious Diseases (8)
Immune System and Allergy (6)
Expanding Knowledge in the Biological Sciences (2)
Disease Distribution and Transmission (incl. Surveillance and Response) (1)
Expanding Knowledge in the Medical and Health Sciences (1)
Health Status (e.g. Indicators of Well-Being) (1)
Preventive Medicine (1)
Reproductive System and Disorders (1)
Respiratory System and Diseases (incl. Asthma) (1)
Filter by Funding Provider
Australian Research Council (8)
Filter by Status
Closed (8)
Filter by Scheme
ARC Future Fellowships (2)
Discovery Early Career Researcher Award (2)
Discovery Projects (2)
Linkage Infrastructure, Equipment and Facilities (2)
Filter by Country
Australia (8)
Filter by Australian State/Territory
VIC (8)
QLD (1)
WA (1)
  • Researchers (12)
  • Funded Activities (8)
  • Organisations (8)
  • Funded Activity

    Discovery Projects - Grant ID: DP120104911

    Funder
    Australian Research Council
    Funding Amount
    $270,000.00
    Summary
    Transport and innate immune properties of DNA in bacterial nano-sized vesicles. All types of living organisms release nano-sized membrane vesicles or “blebs” which they use for intercellular communication and transport of molecules. This project will determine how bacteria package DNA within these vesicles, how this DNA is transported into host cells and how it triggers immune responses in these cells.
    More information
    Funded Activity

    Discovery Early Career Researcher Award - Grant ID: DE120101340

    Funder
    Australian Research Council
    Funding Amount
    $375,000.00
    Summary
    Subversion of innate immune responses by pathogenic Escherichia coli. This project will determine how bacteria that cause diarrhoeal diseases prevent the immune system from signalling efficiently. It will provide important information not only about how the bacteria establish disease, but also provide insight into the host response in the early stages of infection.
    More information
    Funded Activity

    Linkage Infrastructure, Equipment And Facilities - Grant ID: LE140100070

    Funder
    Australian Research Council
    Funding Amount
    $650,000.00
    Summary
    An advanced in vivo imaging facility. An advanced in vivo imaging facility: This project will establish an advanced In Vivo Imaging Facility (IVIF) for examining host-microbe interactions and associated immunological processes within the context of the numerous infectious disease models within the University of Melbourne and associated collaborators. The Zeiss LSM 7MP 2-photon imaging system will provide enhanced capacity to directly visualise cellular and molecular events in real time, with gre .... An advanced in vivo imaging facility. An advanced in vivo imaging facility: This project will establish an advanced In Vivo Imaging Facility (IVIF) for examining host-microbe interactions and associated immunological processes within the context of the numerous infectious disease models within the University of Melbourne and associated collaborators. The Zeiss LSM 7MP 2-photon imaging system will provide enhanced capacity to directly visualise cellular and molecular events in real time, with greater sensitivity and in a broader range of tissues and organs. This will provide the opportunity for novel insights into numerous immunological and host-microbe interactions.
    Read more Read less
    More information
    Funded Activity

    ARC Future Fellowships - Grant ID: FT130100166

    Funder
    Australian Research Council
    Funding Amount
    $731,320.00
    Summary
    Molecular Mechanisms of NOD signalling. Alterations in NOD1 and NOD2 (nucleotide-binding oligomerization domain containing 1 and 2) signalling have been implicated in various human inflammatory diseases. Therefore, a clear understanding of the molecular signalling pathways is important to gain further insights into potential drug targets for the treatment of these diseases. Using novel experimental approaches, this project aims to identify new members of the NOD signalling pathway. It will test .... Molecular Mechanisms of NOD signalling. Alterations in NOD1 and NOD2 (nucleotide-binding oligomerization domain containing 1 and 2) signalling have been implicated in various human inflammatory diseases. Therefore, a clear understanding of the molecular signalling pathways is important to gain further insights into potential drug targets for the treatment of these diseases. Using novel experimental approaches, this project aims to identify new members of the NOD signalling pathway. It will test the effect of pharmacological inhibition of established molecules such as RIPK2 or IAPs in NOD dependent models for human diseases. Outcomes of this study will be of the utmost interest for the treatment of NOD driven diseases such as Crohn's disease, Blau syndrome or asthma.
    Read more Read less
    More information
    Funded Activity

    Linkage Infrastructure, Equipment And Facilities - Grant ID: LE160100097

    Funder
    Australian Research Council
    Funding Amount
    $675,000.00
    Summary
    An Automated Protein Nano-Crystallisation Facility. An automated protein nano-crystallisation facility: The project aims to establish a high throughput protein nanocrystallisation and imaging facility for protein crystallography. Protein crystallography is an important field of biological research, however there are many proteins, such as integral membrane proteins and transient molecular complexes that are more challenging to crystallise. The facility aims to use state-of-the-art imaging and c .... An Automated Protein Nano-Crystallisation Facility. An automated protein nano-crystallisation facility: The project aims to establish a high throughput protein nanocrystallisation and imaging facility for protein crystallography. Protein crystallography is an important field of biological research, however there are many proteins, such as integral membrane proteins and transient molecular complexes that are more challenging to crystallise. The facility aims to use state-of-the-art imaging and crystallisation techniques, including second order nonlinear imaging of chiral crystals (SONICC) imaging and lipid cubic phase approaches, to enable structural studies to be undertaken on challenging proteins. This information is often used for the rational development of therapeutics. The facility would support cutting-edge biological research In Australia.
    Read more Read less
    More information
    Funded Activity

    Discovery Early Career Researcher Award - Grant ID: DE120100691

    Funder
    Australian Research Council
    Funding Amount
    $375,000.00
    Summary
    Argonaute proteins and the mammalian antiviral response. Awarded the Nobel Prize for Medicine in 2006, RNA interference (RNAi) is a natural process that plants use to attack viruses. Humans possess all of the tools for RNAi, but whether it is used for antiviral defense is unknown. This project aims to uncover this immune process which will open new avenues to treat virus infections, from influenza to HIV.
    More information
    Funded Activity

    ARC Future Fellowships - Grant ID: FT110100223

    Funder
    Australian Research Council
    Funding Amount
    $634,528.00
    Summary
    The regulation of anti-viral immunity by host and viral proteins. Anti-viral immunity is initially triggered when specific immune sensors detect viral components within the cell. This project will use a combined functional/structural approach to investigate the specifics of immune activation by a pivotal immune sensor and use this information to understand how influenza A sabotages this specific immune response.
    More information
    Funded Activity

    Discovery Projects - Grant ID: DP110103616

    Funder
    Australian Research Council
    Funding Amount
    $600,000.00
    Summary
    The role of a novel protein, interferon epsilon, in reproductive tract immunity. This project aims to develop a world-first description of a new protein that has a protective role against female reproductive tract infections. This unique protein, called interferon epsilon, was discovered in our laboratory. This project will facilitate development of new therapeutic approaches of benefit in diseases such as Chlamydia and Herpes Simplex Virus.
    More information

    Showing 1-8 of 8 Funded Activites

    Advanced Search

    Advanced search on the Researcher index.

    Advanced search on the Funded Activity index.

    Advanced search on the Organisation index.

    National Collaborative Research Infrastructure Strategy

    The Australian Research Data Commons is enabled by NCRIS.

    ARDC CONNECT NEWSLETTER

    Subscribe to the ARDC Connect Newsletter to keep up-to-date with the latest digital research news, events, resources, career opportunities and more.

    Subscribe

    Quick Links

    • Home
    • About Research Link Australia
    • Product Roadmap
    • Documentation
    • Disclaimer
    • Contact ARDC

    We acknowledge and celebrate the First Australians on whose traditional lands we live and work, and we pay our respects to Elders past, present and emerging.

    Copyright © ARDC. ACN 633 798 857 Terms and Conditions Privacy Policy Accessibility Statement
    Top
    Quick Feedback